Pacira | PCRX - Trade Debtors


Pacira reported $132.42M in Trade Debtors for its fiscal quarter ending in June of 2026.





Trade Debtors Change Date
Astellas Pharma JPY 844.8B 83.04B Jun/2026
Bristol-Myers Squibb USD 13.83B 535M Jun/2026
Cara Therapeutics USD 2.24M 2.26M Mar/2025
Coherus Biosciences USD 18.42M 232.08M Dec/2025
Heron Therapeutics USD 89.59M 8.54M Dec/2025
Ironwood Pharmaceuticals USD 81.89M 5.68M Dec/2024
J&J USD 22.54B 1.21B Mar/2026
Ligand Pharmaceuticals USD 54.8M 6.25M Mar/2026
Nektar Therapeutics USD 3.6M 1.82M Mar/2026
Novo Nordisk DKK 114.94B 8.68B Jun/2026
Omeros USD 8.08M 440K Jun/2024
Pacira USD 132.42M 6.78M Jun/2026
Perrigo USD 697.1M 84.3M Mar/2026
Pfizer USD 16.19B 19M Jun/2026
Supernus Pharmaceuticals USD 211.66M 29.47M Jun/2026
Teva Pharmaceutical Industries USD 3.49B 100M Jun/2026
Xeris Pharmaceuticals USD 56.29M 5.24M Mar/2026
Zoetis USD 1.57B 65M Jun/2026